Number of Shares
25,934.00
Current Holdings Value*
$514,530.00
% of Portfolio
1.1%
Total Estimate Gain
$595,176.47
% of Total Estimate Gain
462.84%

Lazard US Systematic Small Cap Equity Portfolio's ADMA Biologics Inc Holding Summary

As of 2025-03-31, Lazard US Systematic Small Cap Equity Portfolio held 25,934.00 shares of ADMA Biologics Inc(ADMA), totaling $514,530.00. This investment constitutes 1.1% of their stock portfolio, and Lazard US Systematic Small Cap Equity Portfolio now holds 0.01% of the outstanding ADMA Biologics Inc(ADMA) stock.

The initial trade took place in 2021Q4. And since then Lazard US Systematic Small Cap Equity Portfolio has made 5 purchases of ADMA, at an average price of $2.63, for a total of 48,961.00 shares. In addition, there have been 4 sales at an average price of $12.75 for 23,027.00 shares. Based on historical transaction data and ADMA's current price of $16.59, Lazard US Systematic Small Cap Equity Portfolio's estimated gain on his ADMA holdings is $595,176.47, reflecting a 462.84% gain to date.

Lazard US Systematic Small Cap Equity Portfolio ADMA ($16.59) Holding Chart

Lazard US Systematic Small Cap Equity Portfolio ADMA ($16.59) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1